Polymers and hydrogels

Inventors

Yeoman, Roy R. • Fox, Adrian S.

Assignees

NANODERM SCIENCES Inc

Interested in licensing this patent?

MTEC can help explore whether this patent might be available for licensing for your application.

Publication Number

US-8821933-B2

Patent

Publication Date

2014-09-02

Expiration Date


Abstract

Methods and compositions related polymers and hydrogels. In some cases to biodegradable hydrogels for use in medical applications are disclosed. The polymers and hydrogels may be produced from cross-linked dextran and poly(epoxides). The poly(epoxides) may be poloxamers.

Core Innovation

The invention relates to cross-linked dextran-based nanogels that include a polymeric network comprising first block copolymeric segments derived from poloxamer monomers and second polymeric segments derived from unmodified dextran. The linking groups are biocompatible linking groups comprising an ester group, and the biocompatible linking groups crosslink the first block copolymeric segments to the second copolymeric segments, while the nanogel further includes water and a therapeutic agent.

The poloxamer comprises a polyoxyethelene segment in the range of 60 wt. % to 80 wt. % and a polyoxypropylene segment having a molecular mass in the range of 2,500 to 5,000 g/mol. The nanogel size is between 1 and 1000 nm. The described systems include nanogel/hydrogel structures intended to provide controlled release behavior and responsiveness to environment such as pH and temperature.

The documented contexts include drug delivery and wound healing dressings for a moist wound environment, including controlled or continuous release. The materials are described as exhibiting thermoresponsive reversible gel behavior and pH/temperature-responsive release behavior, including retention of a solution having a pH between 2 and 3. The nanogels/hydrogels can incorporate therapeutic agents such as antimicrobial agents and metal-associated components including zinc ions and iron ions, and can include additional agents and biological factors.

Claims Coverage

The partial content includes one independent claim defining a nanogel with four inventive features: poloxamer-derived first block copolymeric segments, unmodified dextran-derived second polymeric segments, biocompatible ester linking groups that crosslink the segments, and water with a therapeutic agent in a 1 to 1000 nm nanogel.

Poloxamer-derived first block segments in a defined composition range

A polymeric network comprising a plurality of first block copolymeric segments derived from poloxamer monomers, wherein the poloxamer comprises a polyoxyethelene segment in the range of 60 wt. % to 80 wt. % and a polyoxypropylene segment having a molecular mass in the range of 2,500 to 5,000 g/mol.

Unmodified dextran-derived second polymeric segments

A plurality of second polymeric segments derived from unmodified dextran.

Biocompatible ester linking groups for crosslinking poloxamer and dextran segments

Biocompatible linking groups comprising an ester group, wherein the biocompatible linking groups crosslink the first block copolymeric segments to the second copolymeric segments.

Therapeutic-agent loaded aqueous nanogel with a defined size range

Water; and therapeutic agent, wherein the size of the nanogel is between 1 and 1000 nm.

Overall claim coverage centers on an ester-linked crosslinked nanogel network combining poloxamer-derived block copolymeric segments with unmodified dextran-derived segments, with water and a therapeutic agent, and a specified nanogel size range. Dependent claims further specify ester-group multiplicity, pH retention between 2 and 3, dextran molecular weight of 43,000 g/mol, and therapeutic-agent selections including antimicrobial and metal-associated options and additional biological factors.

Stated Advantages

Not explicitly described in patent.

Documented Applications

Drug delivery.

Wound healing dressings for a moist wound environment.

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.